The market for vaccines
By: Kalorama Information, LLC.
Contributors: Kalorama Information, LLC.
Publisher: Kalorama Information, Inc.
Published: 2000
Place of publication: New York
Language: eng
Number of pages: 215
Subjects: Aviron Corporation (Firm); Biogen (Firm); Biomira Inc. (Firm); Chiron Corporation (Firm); Merck & Co.; North American Vaccine Inc. (Firm); Pasteur Mérieux Connaught.; SmithKline Beecham Pharmaceuticals.; Vical Inc. (Firm); Wyeth-Ayerst Laboratories.; Vaccines industry.; Vaccines industry -- Forecasting.; Vaccines.; Market surveys.
Description: "In assessing the market for vaccine products, Kalorama Information provides sales data for the 1994 through 1998 historical years, the 1999 base year, and the 2000 through 2004 forecast years.  Revenues are expressed in terms of manufacturers' annual sales and in current U.S. dollars....The market analysis in this report was first conducted through literature searches to determine historical market figures.  Interviews with company representatives from the major manufacturers of vaccine products, as well as individuals at trade associations that track the industry, were conducted to confirm and revise market figures.  Emphasis has been placed on primary, rather than secondary sources, regarding market trends and direction.  This report covers adult and pediatric vaccine products....Kalorama Information also provides an analysis of therapeutic vaccines for human immunodeficiency virus (HIV) infection/acquired immune deficiency syndrome (AIDS) and cancer."
Notes: "February 2000"--t.p.
"KLI13"--t.p.
Table of contents: title: Chapter one: Executive summary. Introduction; title: Scope and methodology; title: Size and growth of the market; title: Trends affecting the market; title: Industry structure and leading competitors; title: The consumer; title: Chapter two: Introduction to vaccines. A brief history: the development of vaccines; title: The immune response; title: Mechanism of action; title: Types of vaccines; title: A new technology: nucleic acid vaccines; title: Adjuvants; title: New vaccine product introductions in 1997, 1998, and 1999; title: Chapter three: Pediatric preventive vaccines. Overview; title: Childhood immunization rates; title: Pediatric vaccine products; title: Cost of pediatric vaccines; title: Pediatric vaccines in development; title: The U.S. market for pediatric vaccines; title: Competitor analysis; title: Market analysis; title: Chapter four: Adult preventive vaccines. Overview; title: Adult immunization rates; title: Recommendations for adult immunization; title: Recommendations for international travelers; title: Adult vaccine products; title: Adult vaccines in development; title: The U.S. market for adult preventive vaccines; title: Competitor analysis; title: Market analysis; title: Chapter five: Therapeutic vaccines. Overview; title: AIDS vaccines; title: Cancer vaccines; title: Chapter six: Issues and trends. Introduction; title: Vaccine safety; title: Thimerosal in vaccines; title: Vaccines and bioterrorism; title: Combination vaccines; title: Innovations in vaccine delivery systems; title: Chapter seven: Market summary. Trends driving the vaccines market; title: Market size and forecast; title: Chapter eight: Competitor profiles. Introduction; title: Aviron Corporation; title: Biogen, Inc.; title: Biomira Inc.; title: Chiron Corporation; title: Merck & Company, Inc.; title: North American Vaccine Inc.; title: Pasteur Mérieux Connaught USA; title: SmithKline Beecham Plc; title: Vical Inc.; title: Wyeth-Ayerst Laboratories; title: Appendix A: Vaccine products; title: Appendix B: Company names and addresses.